Status:

COMPLETED

ReSTOR Natural +3.0D Study In Japan

Lead Sponsor:

Alcon Research

Conditions:

Cataract

Eligibility:

All Genders

20+ years

Phase:

NA

Brief Summary

The objective of this study is to evaluate safety and effectiveness of ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1 when implanted to replace the natural lens following cataract...

Eligibility Criteria

Inclusion

  • Planned bilateral cataract removal by phacoemulsification
  • Potential postoperative best corrected visual acuity of 0.5 or over
  • 5 Diopter (D) or less of astigmatism preoperatively, measured by keratometry

Exclusion

  • Poorly controlled glaucoma
  • Progressive diabetic retinopathy

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT00758576

Start Date

February 1 2008

End Date

December 1 2009

Last Update

December 21 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hayashi Eye Hospital

Fukuoka, Fukuoka, Japan, 812-0011

ReSTOR Natural +3.0D Study In Japan | DecenTrialz